true
Products

Power-Trialysis™ Dialysis Catheter

Flexibility. Utility. Reliability.
Experience the difference.

Contact Us
EDP_1535
Power-Trialysis™ Dialysis Catheter

Ready to learn more? Let’s have a conversation.

Loading

Dialysis Overview

Vascular access and successful dialysis in the ICU:

quote-icon

20–60% of all intensive care unit patients suffer from acute kidney injury1-3

 

  • Dialysis efficiency may affect morbidity and mortality in the critically ill4
  • Dialysis efficiency can be influenced by multiple factors, some of which are:
    • Circuit life5
    • Filtration rate4
  • The benefits of longer and uninterrupted dialysis sessions are well documented:
    • Reduced circuit life leads to adverse patient consequences6

 

 

 

 

 

quote-icon

The Power-Trialysis™ Short-Term Dialysis Catheter is indicated for use in attaining short-term (<30 days) vascular access for hemodialysis, hemoperfusion, and apheresis treatments7

 

  • The distal (purple) lumen is completely independent from the two dialysis lumens and may be used for intravenous therapy, power injection of contrast media, and central venous pressure monitoring7
  • The maximum recommended infusion rate is 5 mL/sec for power injection of contrast media7
  • Oval catheter design resists kinking7
  • Made of thermosensitive polyurethane, which softens when exposed to body temperature7
  • Symmetrical tip allows for 2% recirculation on average in forward and reverse7

 

 

quote-icon

In two US hospitals (n=1,037), switching to Power-Trialysis™† resulted in improvement in several factors known to impact dialysis efficiency:8

 

 

†Before the switch, the hospitals used: Mahurkar Elite IC Catheter Kit, 12 Fr x 13 cm, Curved, 3-Lumen Medtronic, Fridley, MN; Covidien Mahurkar Elite 12F Dual Lumen Catheter 16cm, curved, Kit Medtronic, Fridley, MN; High-Pressure Triple Lumen Acute Dialysis Catheter IC Tray, 20cm, Curved Extensions, 12 Fr, Cardinal Health, Dublin, OH. Post-switch the hospitals utilized a single catheter: BD Power-Trialysis Short-Term Curved Extension Dialysis Catheter in full procedure trays, 15 cm and 20 cm Insertion lengths’ ‡p<0.05

Product Overview

When your patient's therapy needs include a central line along with acute dialysis treatment, choose the Power-Trialysis™ Catheter. It is indicated for use, with a third internal lumen for intravenous therapy, power injection of contrast media, and central venous pressure monitoring, is indicated for use in attaining short-term (less than 30 days) vascular access for hemodialysis, hemoperfusion, and apheresis treatments. The catheter is intended to be inserted in the jugular, femoral, or subclavian vein as required. The maximum recommended infusion rate is 5 mL/sec for power injection of contrast media.

In today's environment, reducing exposure to bloodborne pathogens and bacteria to the clinician and the patient is extremely important. Having a central line integrated within an acute dialysis catheter may reduce clinician exposure with fewer dressings to maintain and may help improve patient experience by having fewer vascular access sites.

The Power-Trialysis™ Catheter family is made up of 12 and 13 Fr triple-lumen, short-term dialysis catheters that come in various lengths and configurations.

All Power-Trialysis™ Catheters are offered in standard kits as well as maximal barrier precaution trays.

true
  • Power-Trialysis Straight

    Straight
  • Power-Trialysis Slim Curved

    Curved
  • Power-Trialysis Alpha Curved

    Alphacurve

 

 

 

    Product Benefits

    • The oval catheter shaft demonstrated better kink resistance than competitive triple-lumen dialysis catheters*
    • The thermosensitive polyurethane catheter shaft provides stiffness during insertion, but softens at body temperature
    • Power-Trialysis™ Slim-Cath™ Catheter 12 Fr demonstrated ~46% smaller kink diameter than a competitor*

     

    *As demonstrated through simulated testing. Bench test results may not necessarily be indicative of clinical performance.

     

     

    • The distal purple power-injectable lumen is identifiable by its purple color and may be used for intravenous therapy, power injection of contract media and central venous pressure monitoring; and can also be accessed for blood draws and infusion of medications
    • Multiple catheter insertion lengths of 12.5 cm, 15 cm, 20 cm, 24 cm and 30 cm (lengths vary per catheter configuration)
    • Straight and curved catheter configurations
    • Standard kit and full max barrier tray options

     

     

    • Demonstrated a reliable flow rate up to 400 mL/min and recirculation of 2% on average through simulated testing*
    • Enables clinicians to facilitate compliance with federal regulations and guidelines
       

    *As demonstrated through simulated testing. Results may not be indicative of actual clinical performance. Different tests may yield different results.

     

     

    Gravity flow rate

    Gravity flow rate of the central lumen

    Straight catheter and curved extension legs

    Insertion lengthGravity flow rate
    30 cm2258 mL/hr
    24 cm2634 mL/hr
    20 cm2830 mL/hr
    15 cm3333 mL/hr
    12.5 cm3721 mL/hr

     

    AlphacurveTM Catheter

    Insertion lengthGravity flow rate
    24 cm2149 mL/hr
    20 cm2387 mL/hr
    15 cm2539 mL/hr
    12.5 cm3092 mL/hr

     

    Slim-CathTM Catheter

    Insertion lengthGravity flow rate
    30 cm2376 mL/hr
    24 cm2773 mL/hr
    20 cm3081 mL/hr
    15 cm3656 mL/hr
    12.5 cm3922 mL/hr

    Power-Trialysis™ Short-Term Dialysis Catheters

    Sort by:

    Power-Trialysis™ Slim-Cath™ Short-Term Dialysis Catheters

    Sort by:

    StruXure™ Guidewire

    Sort by:
    Frequently Asked Questions

    A surgical gown.

    Contrast-induced nephropathy is most commonly defined as an elevation of serum creatinine of more than 25% or greater than or equal to 0.5mg/dl from baseline within 48 hours.

    The rate of recirculation is less than 2% on average in both forward and reverse directions, when tested in-vitro. *

    Power Trialysis comes in straight curved and alpha curved configurations.

    The extension legs are polyurethane.  The catheter shaft and tip are made from thermosensitive bodysoft polyurethane which softens at body temperature.

    Power-Trialysis and Power-Trialysis Slim-Cath flow rate is 400 mL/min. for both straight and curved.  The Power-Trialysis Alphacurve® flow rate is 350mL/min.

    No, there are no repair kits for Power-Trialysis catheters.

    Each Power-Trialysis kit and tray includes a 11-13 Fr. and a 12-14 Fr. dualator vessel dilator.  Two dilators are provided to progressively help widen the insertion site.

    The Power-Trialysis catheter luer-lock connector and exit site are compatible with povidone iodine, chlorhexidine gluconate 2% solution, chlorhexidine gluconate 4% solution, 0.55% sodium hypochlorite solution, hydrogen peroxide, chlorhexidine patches, and bacitracin zinc ointments in petrolatum bases.  Refer to the instructions for use for a detailed list of warnings.

    The catheter tip must be in the lower superior vena cava for optimal performance. If placed femorally, the catheter tip should be placed in the inferior vena cava to minimize recirculation. Catheters greater than 24 cm are intended for femoral vein insertion. CAUTION: For jugular and subclavian insertion, the catheter tip should not be located in the right atrium. WARNING: Verification of the catheter tip location must be confirmed by x-ray.

    The physician will determine this based on the patients needs. The third lumen Power-Trialysis catheter can be used for other therapies concurrent with dialysis.  The third lumen is completely independent from the two dialysis lumens and is indicated for power injection of contrast media, and central venous pressure monitoring, and can be used for blood draws and medication delivery without the need for separate access.

    The third lumen should be locked per hospital protocol for central lines. The priming volume is printed on the extension leg. WARNING: Alcohol should not be used to lock, soak or declot polyurethane Dialysis Catheters because alcohol is known to degrade polyurethane catheters over time with repeated and prolonged exposure.

    The largest guidewire that may be used is a 0.035 in (0.89 mm).

    The catheter shaft is oval for two reasons. First, the oval shaft improves the catheter’s kink resistance. Second, the oval shape allows for the internal kidney-shaped lumen design which provides high flow rates of 400 mL/min.

    Resources
    document-icon.svg
    Literature
    BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.
    Learn more
    true

    Power-Trialysis™ Acute Dialysis Catheters

    Power-Trialysis™ Acute Dialysis Catheters
    Ready to learn more? Let’s have a conversation.
    Reference
    1. Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. Aug 2015;41(8):1411-23. doi:10.1007/s00134-015-3934-7
    2. Hoste EA, Schurgers M. Epidemiology of acute kidney injury: how big is the problem? Crit Care Med. 2008 Apr;36(4 Suppl):S146-51. doi: 10.1097/CCM.0b013e318168c590
    3. Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. Aug 25 2012;380(9843):756-66. doi:10.1016/S0140-6736(11)61454-2
    4. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. Jul 1 2000;356(9223):26-30. doi:10.1016/S0140-6736(00)02430-2
    5. Fealy N, Baldwin I, Bellomo R. The effect of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. Crit Care Resusc. Dec 2002;4(4):266-70.
    6. Zhang Z, Ni H, Lu B. Variables associated with circuit life span in critically ill patients undergoing continuous renal replacement therapy: a prospective observational study. ASAIO J. Jan-Feb2012;58(1):46-50. doi:10.1097/MAT.0b013e31823fdf20
    7. Data on file
    8. Gilmore N, Alsbrooks K, Hoerauf K. The Association Between Catheter Type and Dialysis Efficiency: A Retrospective Data Analysis at Two US-based ICUs. Critical Care Explorations. Jan 2023;5(1):e0795. doi:10.1097/CCE.0000000000000795

    Please consult product labels, IFU, and package inserts for any indications, contraindications, hazards, warnings, cautions, and instructions for use.

    Available sizes: 12 & 13 Fr.

    BD-19968 (12/23)

    true